SAN CLEMENTE, CA, Aug. 31, 2020 (GLOBE NEWSWIRE) —  via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (OTC Pink: GWHP) today announced Goldman Small Cap Research has published an initial analyst report covering GWHP’s outlook. GWHP is an emerging rapid diagnostic point-of-care (PoC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. GWHP was awarded a CE Mark for its high quality, rapid anti-body test for COVID-19 and an EUA filing with the FDA is pending approval. This report carries a price target. To view the new research report, along with disclosures and disclaimers, or to download it in its entirety, please visit https://bit.ly/3lz68yr. About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co. Goldman Small Cap Research – GWHP To view an enhanced version of this graphic, please visit:https://finance.yahoo.com/news/goldman-small-cap-research-issues-120000066.html This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,”   Read more…